Active Awards Portfolio Dashboard
It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.

Filter Awards
Disease![]() |
Cell Type | Therapeutic or Technology | Institution | Stage | Project Objective | Details |
---|---|---|---|---|---|---|
Immune Disease, Severe Combined Immunodeficiency, X-linked (X-SCID) |
Adult Stem Cell | Gene-modified, personalized cell therapy | St. Jude |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Intervertebral disc degeneration | iPS Cell | Donor cell therapy | Cedars-Sinai |
![]() |
Proof of Concept | |
Intestinal Disease | iPS Cell | Exploring disease mechanisms | Cedars-Sinai |
![]() |
Proof of Concept, Tool/Resources/Bottleneck | |
Intestinal Disease, Neurological Disorders |
iPS Cell | Donor cell therapy | CHLA |
![]() |
Pre-IND/IDE or Equivalent | |
IPEX Syndrome | Adult Stem Cell | Gene-modified, personalized cell therapy | Stanford |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
IPEX Syndrome | Adult Stem Cell | Gene-modified, personalized cell therapy | ImmunoVec |
![]() |
Pre-IND/IDE or Equivalent | |
Kidney Disease | Somatic Cell | Gene Therapy, cell free | UCSF |
![]() |
Development Candidate, Proof of Concept | |
Kidney Failure | Adult Stem Cell | Donor cell therapy | Stanford |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Kidney Failure | Adult Stem Cell | Donor cell therapy | Medeor Therapeutics |
![]() |
Clinical Trial, Phase 3 | |
Kidney Failure | Adult Stem Cell | Device | UC Davis |
![]() |
Pre-IND/IDE or Equivalent | |
Kidney Failure | Adult Stem Cell | Donor cell therapy | Stanford |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Leukemia | Cancer Stem Cell | Biologic | UCLA |
![]() |
Development Candidate | |
Leukemia, Acute Myeloid (AML) | Cancer Stem Cell | Gene-modified, personalized cell therapy | UCSF |
![]() |
IND | |
Leukemia, Acute Myeloid (AML) | Cancer Stem Cell | Gene-modified, personalized cell therapy | UCSF |
![]() |
Pre-IND/IDE or Equivalent | |
Leukemia, Acute Myeloid (AML) | Cancer Stem Cell | Antibody | Immune-Onc Therapeutics |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Liver Disease | iPS Cell | Diagnostic Test | UCSF |
![]() |
Development Candidate, Proof of Concept | |
Liver Disease | iPS Cell | Gene-modified, donor cell therapy | CHLA |
![]() |
Development Candidate, Proof of Concept | |
Lung Cancer | Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Lung Disease, Fibrosis | Adult Stem Cell | Small molecule therapy | Rubedo Life Sciences Inc. |
![]() |
Development Candidate, Proof of Concept | |
Melanoma | Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Pre-IND/IDE or Equivalent | |
Melanoma | Adult Stem Cell | Vaccine | UCLA |
![]() |
Proof of Concept | |
Metabolic Disorders, Neurological Disorders |
Somatic Cell | Stanford |
![]() |
IND | ||
Metabolic Disorders | Adult Stem Cell | Gene-modified, personalized cell therapy | Rampart Bioscience |
![]() |
IND | |
Metabolic Disorders | Somatic Cell | Gene-modified, personalized cell therapy | Immusoft Corporation |
![]() |
Pre-IND/IDE or Equivalent | |
Multiple Myeloma | Adult Stem Cell | Gene-modified, donor cell therapy | UCLA |
![]() |
Pre-IND/IDE or Equivalent | |
Multiple Myeloma | Adult Stem Cell | Personalized cell therapy | UCLA |
![]() |
Pre-IND/IDE or Equivalent | |
Multiple Myeloma | Somatic Cell | Gene-modified, personalized cell therapy | UCSF |
![]() |
Development Candidate, Proof of Concept | |
Multiple Myeloma | Adult Stem Cell | Gene-modified, personalized cell therapy | Poseida Therapeutics |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Multiple Sclerosis | Adult Stem Cell | Small molecule therapy | Scripps |
![]() |
Development Candidate, Proof of Concept | |
Skeletal/Smooth Muscle disorders |
Embryonic Stem Cell, iPS Cell |
Exosomes based therapy | Stanford |
![]() |
Development Candidate, Proof of Concept | |
Muscle Injury | Adult Stem Cell | Personalized cell therapy | UC Davis |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Muscle Injury | Adult Stem Cell | Other Components | UCSF |
![]() |
Development Candidate, Proof of Concept | |
Muscular Dystrophy | Protein/peptide therapy | Juvena Therapeutics Inc |
![]() |
Pre-IND/IDE or Equivalent | ||
Neurological Disorders | iPS Cell | Gene Therapy, cell free | Navega Therapeutics |
![]() |
Development Candidate, Proof of Concept | |
Neurological Disorders, Sanfilippo Syndrome/MPS III |
Embryonic Stem Cell | Gene-modified, donor cell therapy | Lundquist Institute |
![]() |
Development Candidate, Proof of Concept | |
Neurological Disorders, Sanfilippo Syndrome/MPS III |
iPS Cell | Gene-modified, personalized cell therapy | UC Irvine |
![]() |
Development Candidate, Proof of Concept | |
Neurological Disorders, Other |
Adult Stem Cell | Gene-modified, personalized cell therapy | UCSD |
![]() |
Pre-IND/IDE or Equivalent | |
Neurological Disorders | Gene Therapy, cell free | Mahzi Therapeutics |
![]() |
Pre-IND/IDE or Equivalent | ||
Neurological Disorders | Adult Stem Cell | Gene-modified, personalized cell therapy | UC Davis |
![]() |
IND | |
Osteoarthritis | Somatic Cell | Gene Therapy, cell free | Genascence Corporation |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Other | Adult Stem Cell | Protein/peptide therapy | Intact Therapeutics, Inc. |
![]() |
Development Candidate, Proof of Concept | |
Other | iPS Cell | Model system development | Greenstone Biosciences |
![]() |
Tool/Resources/Bottleneck | |
Ovarian Cancer | Adult Stem Cell | Gene-modified, donor cell therapy | COH |
![]() |
Pre-IND/IDE or Equivalent | |
Ovarian Cancer | Adult Stem Cell | Gene-modified, donor cell therapy | UCLA |
![]() |
Development Candidate | |
Ovarian Cancer | iPS Cell | Gene-modified, donor cell therapy | UCSD |
![]() |
Development Candidate, Proof of Concept | |
Pancreatic Cancer | Cancer Stem Cell | Antibody | UCSD |
![]() |
Development Candidate | |
Pancreatic Cancer | Cancer Stem Cell | Small molecule therapy | UCSD |
![]() |
Development Candidate, Proof of Concept | |
Parkinson's Disease | iPS Cell | Donor cell therapy | Ryne Bio |
![]() |
IND | |
Parkinson's Disease | Vital Research Opportunity | Gene Therapy, cell free | Brain Neurotherapy Bio |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Prostate Cancer | iPS Cell | Gene-modified, donor cell therapy | COH |
![]() |
Development Candidate, Proof of Concept |